Background Long term quality of life is becoming increasingly crucial as survival following partial pancreatectomy rises. The purpose of this study was to investigate the difference in glucose dysregulation after pancreaticoduodenectomy (PD) or distal pancreatectomy (DP).
Methods In this prospective observational study from 2015 to 2018, 224 patients who underwent partial pancreatectomy were selected: 152 (67.9%) received PD and 72 (32.1%) received DP. Comprehensive assessment for glucose regulation, including a 75 g oral glucose tolerance test was conducted preoperatively, and 1, 12, and 52 weeks after surgery. Patients were further monitored up to 3 years to investigate development of new-onset diabetes mellitus (NODM) in patients without diabetes mellitus (DM) at baseline or worsening of glucose regulation (≥1% increase in glycosylated hemoglobin [HbA1c]) in those with preexisting DM.
Results The disposition index, an integrated measure of β-cell function, decreased 1 week after surgery in both groups, but it increased more than baseline level in the PD group while its decreased level was maintained in the DP group, resulting in a between-group difference at the 1-year examination (P<0.001). During follow-up, the DP group showed higher incidence of NODM and worsening of glucose regulation than the PD group with hazard ratio (HR) 4.29 (95% confidence interval [CI], 1.49 to 12.3) and HR 2.15 (95% CI, 1.09 to 4.24), respectively, in the multivariate analysis including dynamic glycemic excursion profile. In the DP procedure, distal DP and spleen preservation were associated with better glucose regulation. DP had a stronger association with glucose dysregulation than PD.
Conclusion Proactive surveillance of glucose dysregulation is advised, particularly for patients who receive DP.
Citations
Citations to this article as recorded by
Impaired insulin secretion via the Wnt5a/β-catenin pathway contributes to diabetes development in pancreatic cancer Minyoung Lee, Ho Seon Park, Hyung Sun Kim, ARim Choi, Ji Hae Nahm, Beom Jin Lim, Jong Suk Park, Chul Woo Ahn, Younhee Ko, Dong Ki Lee, Dong Sup Yoon, Joon Seong Park, Shinae Kang Experimental & Molecular Medicine.2026; 58(1): 272. CrossRef
Machine learning-based prediction of long-term new-onset diabetes mellitus risk after pancreaticoduodenectomy using radiomics Jihyun Yoon, Seon Min Lee, Byoungduck Han, Yang-Hyun Kim, Young Jae Kim, Jaehun Yang, Yeon Ho Park, Doojin Kim, Doo-Ho Lee, Kwang Gi Kim DIGITAL HEALTH.2026;[Epub] CrossRef
New-onset diabetes mellitus after distal pancreatectomy research status, trends, and risk factors Alapati Waili, Maidina Ruzimaimaiti, Yunzhen Jia, Wei Han International Journal of Surgery.2026; 112(3): 8251. CrossRef
How Much Pancreas Is Too Much?: Optimal Pancreas Resection Volume to Prevent Diabetes Mellitus After Left-Sided Pancreatectomy Inhyuck Lee, Young Jae Cho, Go-Won Choi, Younsoo Seo, Yoon Soo Chae, Youngmin Han, Hye-Sol Jung, Wooil Kwon, Joon Seong Park, Jin-Young Jang HPB.2026;[Epub] CrossRef
Treatment of Pancreatic Neuroendocrine Tumors: Beyond Traditional Surgery and Targeted Therapy Khyati Bidani, Angela G. Marinovic, Vishali Moond, Prateek Harne, Arkady Broder, Nirav Thosani Journal of Clinical Medicine.2025; 14(10): 3389. CrossRef
Incidence and risk factors for new-onset diabetes mellitus (NODM) in post-pancreatectomy patients diagnosed with pancreatic adenocarcinoma (PAC): A systematic review Adavikolanu Kesava Ramgopal, Chandramouli Ramalingam, Kaliyath Soorej Balan, K.S. Abhishek Raghava, Kondapuram Manish, Kari NagaSai Divya, Yadala Ambedkar, Varthya Shobhan Babu, Kondeti Ajay Kumar Oncoscience.2025; 12: 203. CrossRef